Replimune Group Inc (REPL)
6.46
+0.31
(+5.04%)
USD |
NASDAQ |
Apr 26, 14:42
Replimune Group Price: 6.46 for April 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 25, 2024 | 6.18 | 6.41 | 5.86 | 6.15 | 781297.0 |
| Apr 24, 2024 | 6.41 | 6.66 | 6.20 | 6.33 | 631812.0 |
| Apr 23, 2024 | 6.47 | 6.77 | 6.385 | 6.42 | 1.157M |
| Apr 22, 2024 | 6.56 | 6.669 | 6.22 | 6.42 | 551481.0 |
| Apr 19, 2024 | 6.90 | 7.07 | 6.33 | 6.45 | 866786.0 |
| Apr 18, 2024 | 7.20 | 7.43 | 6.95 | 6.97 | 1.126M |
| Apr 17, 2024 | 7.19 | 7.33 | 7.14 | 7.21 | 1.138M |
| Apr 16, 2024 | 7.01 | 7.25 | 6.92 | 7.15 | 684229.0 |
| Apr 15, 2024 | 7.14 | 7.26 | 7.07 | 7.12 | 671857.0 |
| Apr 12, 2024 | 7.17 | 7.29 | 6.97 | 7.14 | 917240.0 |
| Apr 11, 2024 | 7.07 | 7.31 | 6.82 | 7.19 | 710041.0 |
| Apr 10, 2024 | 7.01 | 7.03 | 6.72 | 6.96 | 913825.0 |
| Apr 09, 2024 | 7.09 | 7.34 | 7.085 | 7.28 | 708204.0 |
| Apr 08, 2024 | 7.43 | 7.45 | 7.12 | 7.12 | 574896.0 |
| Apr 05, 2024 | 7.47 | 7.72 | 7.095 | 7.36 | 821247.0 |
| Apr 04, 2024 | 7.11 | 7.47 | 7.11 | 7.34 | 885555.0 |
| Apr 03, 2024 | 7.05 | 7.17 | 6.90 | 7.06 | 1.008M |
| Apr 02, 2024 | 7.49 | 7.66 | 7.11 | 7.13 | 953300.0 |
| Apr 01, 2024 | 8.17 | 8.17 | 7.67 | 7.73 | 945367.0 |
| Mar 28, 2024 | 8.23 | 8.46 | 8.04 | 8.17 | 1.099M |
| Mar 27, 2024 | 7.80 | 8.25 | 7.65 | 8.25 | 1.052M |
| Mar 26, 2024 | 8.03 | 8.23 | 7.23 | 7.69 | 1.000M |
| Mar 25, 2024 | 8.13 | 8.35 | 7.98 | 8.05 | 693049.0 |
| Mar 22, 2024 | 8.22 | 8.42 | 8.16 | 8.20 | 688537.0 |
| Mar 21, 2024 | 8.19 | 8.57 | 8.06 | 8.20 | 721833.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.15
Minimum
Apr 25 2024
52.65
Maximum
Dec 01 2020
21.39
Average
19.20
Median
May 13 2020
Price Benchmarks
| Esperion Therapeutics Inc | 1.905 |
| SI-BONE Inc | 14.52 |
| Gossamer Bio Inc | 0.6654 |
| Olema Pharmaceuticals inc | 9.81 |
| NovaBay Pharmaceuticals Inc | 0.0831 |
Price Related Metrics
| Price to Book Value | 0.9407 |
| Earnings Yield | -48.92% |
| Market Cap | 396.57M |